NEW YORK (GenomeWeb News) – Sequenom said in its Form 10-K filed with the US Securities and Exchange Commission this week that the US Patent and Trademark Office on March 12 declared a patent interference between US Patent No. 8,008,018 held by Verinata Health, now part of Illumina, and Sequenom's pending patent application No. 13/070,275. In February 2012, Verinata and Stanford University sued Sequenom alleging it infringes the patent through the offering of its MaterniT21 Plus test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.